Kenalog

Triamcinolone acetonide, the active ingredient in Kenalog, is a corticosteroid presented as a sterile injectable solution for intra‑articular, intralesional and intramuscular use. It belongs to the anti‑inflammatory and immunosuppressant therapeutic class and is employed to reduce inflammation in joint disorders and dermatologic lesions in adult patients.

GNH USA supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Kenalog is used to treat inflammatory and immune‑mediated conditions affecting joints, skin and systemic sites.

Osteoarthritis: reduces joint inflammation and pain when injected intra‑articularly. Rheumatoid arthritis: decreases synovial inflammation and limits joint damage via intra‑articular injection. Keloids and hypertrophic scars: softens scar tissue and limits excessive collagen formation when given intralesionally. Dermatologic inflammatory conditions (e.g., psoriasis, eczema): alleviates redness, swelling and itching through intralesional injection. Systemic inflammatory disorders: provides broad anti‑inflammatory effect when administered intramuscularly.

Kenalog may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: transient discomfort at the injection area. - Localized swelling or bruising: mild tissue reaction. - Transient hyperglycemia: temporary rise in blood glucose. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: increased susceptibility to bacterial or fungal infections. - Allergic reaction (anaphylaxis): rapid onset of hives, breathing difficulty. - Cushingoid appearance: facial rounding and weight gain with prolonged use.

Before using Kenalog, clinicians should consider several precautionary measures to ensure safe therapy.

Assess infection risk: avoid use in active systemic infections. Monitor blood glucose: patients with diabetes may experience hyperglycemia. Evaluate adrenal function: prolonged therapy can suppress the hypothalamic‑pituitary‑adrenal axis. Use caution in glaucoma: corticosteroids may increase intra‑ocular pressure. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Kenalog can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Systemic CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid levels and risk of toxicity. - Live vaccines: immunosuppression can reduce vaccine effectiveness and increase infection risk. - Systemic anticoagulants (e.g., warfarin): heightened risk of bleeding.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use may increase gastrointestinal ulcer risk. - Antidiabetic agents: corticosteroid‑induced hyperglycemia may require dose adjustment.